Respiratory system involvement in brucellosis: the results of the Kardelen study H Erdem, A Inan, N Elaldi, R Tekin, S Gulsun, C Ataman-Hatipoglu, ... Chest 145 (1), 87-94, 2014 | 46 | 2014 |
Evaluation of tularaemia courses: a multicentre study from Turkey H Erdem, D Ozturk‐Engin, M Yesilyurt, O Karabay, N Elaldi, G Celebi, ... Clinical Microbiology and Infection 20 (12), O1042-O1051, 2014 | 38 | 2014 |
Lymphocyte-to-C-reactive protein ratio may serve as an effective biomarker to determine COVID-19 disease severity T Bal, S Dogan, M Cabalak, E Dirican Turkish Journal of Biochemistry 46 (1), 23-28, 2021 | 29 | 2021 |
Sağlık çalışanlarının burunlarından izole edilen koagülaz pozitif ve negatif stafilokoklarda metisilin direnci ve slime pozitifliği İ Çelik, M Cihangiroğlu, E Sevim, M Çabalak, A Akbulut Fırat Tıp Dergisi 10 (3), 123-126, 2005 | 23 | 2005 |
Beclin-1, an autophagy-related protein, is associated with the disease severity of COVID-19 HM Okuyan, S Dogan, T Bal, M Cabalak Life sciences 278, 119596, 2021 | 16 | 2021 |
Oxidative stress index can be a new marker related to disease severity in COVID-19 S Doğan, T Bal, M Çabalak, N Dikmen, H Yaqoobi, O Ozcan Turkish Journal of Biochemistry 46 (4), 349-357, 2021 | 15 | 2021 |
YOĞUN BAKIMDA İZOLE EDİLEN PSEUDOMONAS SPP. SUŞLARINDA METALLO-BETA-LAKTAMAZ SIKLIĞININ ARAŞTIRILMASI K DEMİRDAĞ, M CABALAK, M ÖZGÜLER Ankem Derg 25 (3), 150-156, 2011 | 13 | 2011 |
NS5A resistance–associated substitutions in chronic hepatitis C patients with direct acting antiviral treatment failure in Turkey M Sayan, FS Yıldırım, S Akhan, AA Yıldırım, G Şirin, M Cabalak, M Demir, ... International Journal of Infectious Diseases 95, 84-89, 2020 | 9 | 2020 |
Serum periostin levels in COVID‐19: Is it useful as a new biomarker? M Cabalak, S Doğan, T Bal, N Dikmen International Journal of Clinical Practice 75 (11), e14728, 2021 | 5 | 2021 |
Pentraxin-3: A Novel Marker for Indicating Liver Fibrosis in Chronic Hepatitis B Patients? ŞÖ Balin, M Cabalak, AS Tartar, Ü Kazancı, S Telo, K Demirdağ, ... The Turkish Journal of Gastroenterology 32 (7), 581, 2021 | 5 | 2021 |
Hatay ilindeki importe sıtma olgularının retrospektif analizi: 10 yıl içerisinde 75 olgu Sİ Şahin, M Çabalak, T Bal, S Ocak, Y Önlen, G Çulha Türkiye Parazitoloji Derneği, 2019 | 5 | 2019 |
Hastane kaynaklı koagülaz negatif stafilokoklarda fosfomisin duyarlılığı metisilin direnci ve slaym yapımı ilişkisi İ ÇELİK, M CİHANGİROĞLU, M ÇABALAK, E SEVİM, A AKBULUT, ... ANKEM Dergisi 19 (3), 139-143, 2005 | 5 | 2005 |
Incidence and predictors of direct-acting antiviral treatment failure in Turkish patients with chronic hepatitis C genotype 1b infection M Cabalak, T Bal, Y Onlen, M Demir Tropical Doctor 50 (2), 141-146, 2020 | 4 | 2020 |
Comparison of immunological and virological recovery with rapid, early, and late start of antiretroviral treatment in naive plwh: real-world data F Sarıgül Yıldırım, A Candevir, S Akhan, S Kaya, M Çabalak, G Ersöz, ... International Journal of General Medicine, 1867-1877, 2023 | 3 | 2023 |
Sofosbuvir and ribavirin in Turkish non-cirrhotic chronic hepatitis C patients infected with genotype 2 or 3 T Bal, M Cabalak | 3 | 2020 |
Hıv pozitif olgularda viral hepatit ve sifiliz koinfeksiyonu seroprevalansının irdelenmesi M Çabalak, T Bal Bilimsel Tıp Yayınevi, Tuba Yıldırım, 2020 | 3 | 2020 |
Occult hepatitis B infection in Turkish HIV‐infected patients: A multicentre, retrospective, cross‐sectional study, Schindler study G Ünlü, Y Yıldız, MM Ören, M Cabalak, Ö Mete, S Kömür, F Yıldırım, ... International Journal of Clinical Practice 75 (9), e14358, 2021 | 2 | 2021 |
Intravenous drug use rates and results of direct-acting antiviral treatment in prisoner patients M Çabalak, T Bal Galenos Yayınevi, 2020 | 2 | 2020 |
THU-149-Efficiency and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey B Kurtaran, F Sarýgül, M Cabalak, S Kaya, ND Sarý, H Karsen, E Zerdali, ... Journal of Hepatology 70 (1), e227, 2019 | 2 | 2019 |
Kan Kültürlerinde Salmonella typhi Üremesi Olan Tifo Olgularının İrdelenmesi A Bilici, M Çabalak, A Denk, K Demirdağ Fırat Tıp Dergisi 19 (1), 22-24, 2014 | 2 | 2014 |